Page 135 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg

References
1. SPC Teysuno (tegafur/gimeracil/oteracil) 05 April 2017.
2. Cubero DI, Cruz FM, Santi P, Silva ID, Del GA. Tegafur-uracil is a safe alternative for the treatment
of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof
of principle. Ther Adv Med Oncol. 2012;4(4):167-172.
3. Deenen MJ, Terpstra WE, Cats A, Boot H, Schellens JH. Standard-dose tegafur combined with
uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine. Ann Intern Med. 2010;153(11):767-768.
4
Supplement
133